First quarter 2025Net sales in the quarter amounted to SEK 535.4 m (412.9), which corresponds to net sales growth of 30% (25%). The growth was primarily driven by our ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

The JPMorgan EPS for the latest quarter is 20.42.

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Microsoft — Stock in the technology behemoth climbed more than 6% on the heels of better-than-expected third-quarter results ...

Goldman Sachs keeps Neutral on Pfizer, citing unclear product growth plans and focus on M&A amid changing market valuations ...

Century Therapeutics Inc. company and executive profile by Barron's. View the latest IPSC company infomation and executive bios.

Pfizer is deeply undervalued, and has a high dividend yield, and I see tons of institutions and analysts buying the dip. Read ...

Real-time index price for Dow Jones Industrial Average (DOWI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Pfizer's robust product pipeline and consistent R&D investments position it well for future growth. See why I rate PFE stock ...

ACADIA Pharmaceuticals Inc. company and executive profile by Barron's. View the latest ACAD company infomation and executive bios.

Last year, Pfizer generated more than $9.8 billion in free cash flow, and it finished 2024 with $20.5 billion in cash and short-term investments. With strong financials, the company may be in a ...